IL2 and neoplasm: There is some experimental evidence highlighting the potential of HT to impede tumor progression by modulating the expression levels of IFN-γ, PD-1, IL-17A, and MHC I. Notably, IL-2, IL-10, and IL-17A have been implicated in inhibiting immune escape mechanisms.